Achilles Therapeutics Expands UK and U.S. Manufacturing Capabilities

SourceContract Pharma
Date Published04/12/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Achilles Therapeutics
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2022
Domestically, the work will be done:In-house
Country(ies) from which reshored:United Kingdom
City reshored to:King of Prussia,
State(s) reshored to:PA
If relevant, work nearshored to:-
What non-domestic negative factors made offshoring less attractive?Supply chain interruption risk/Natural disaster risk/Political instability
Find Reshoring Articles